AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012
Sep 14, 2012
30583_dirs_2012-09-14_6d99e17f-a6e2-4753-b16a-0f6e5b056011.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-09-05
Reporting Person: Ajer Jeffrey Robert (SVP, Chief Commercial Of)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10570 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $38.59 | 2018-05-21 | Common Stock (28000) | Direct | |
| Stock Option (right to buy) | $17.86 | 2019-05-11 | Common Stock (1000) | Direct | |
| Stock Option (right to buy) | $14.39 | 2019-05-11 | Common Stock (6250) | Direct | |
| Stock Option (right to buy) | $21.51 | 2020-05-11 | Common Stock (30000) | Direct | |
| Stock Option (right to buy) | $37.46 | 2022-05-11 | Common Stock (13000) | Direct | |
| Stock Option (right to buy) | $28.23 | 2021-05-30 | Common Stock (23700) | Direct |
Footnotes
F1: Original option grant vests 6/48th on November 22, 2008 and 1/48th on the 22nd of each month thereafter.
F2: Original option grant vests 6/48th on May 17, 2009 and 1/48th on the 17th of each month thereafter.
F3: Original option grant vests 6/48th on November 12, 2009 and 1/48th on the 12th of each month thereafter.
F4: Original option grant vests 6/48th on November 12, 2010 and 1/48th on the 12th of each month thereafter.
F5: Original option grant vests 6/48th on November 8, 2012 and 1/48th on the 8th of each month thereafter.
F6: Original option grant vests 6/48th on December 1, 2011 and 1/48th on the 1st of each month thereafter.